Digital Repository

Development of an in-house ELISA as an alternative method for the serodiagnosis of leptospirosis

Show simple item record

dc.contributor.author Niloofa, R.
dc.contributor.author Karunanayake, L.
dc.contributor.author de Silva, H.J.
dc.contributor.author Premawansa, S.
dc.contributor.author Rajapakse, S.
dc.contributor.author Handunnetti, S.
dc.date.accessioned 2021-02-16T07:28:49Z
dc.date.available 2021-02-16T07:28:49Z
dc.date.issued 2021
dc.identifier.citation International Journal of Infectious Diseases. 2021; 105: 135-40. en_US
dc.identifier.issn 1201-9712 (Print)
dc.identifier.issn 1878-3511 (Electronic)
dc.identifier.issn 1201-9712 (Linking)
dc.identifier.uri http://repository.kln.ac.lk/handle/123456789/21989
dc.description Indexed in MEDLINE en_US
dc.description.abstract BACKGROUND: Leptospirosis is most often clinically diagnosed and a laboratory test with high diagnostic accuracies is required. METHODOLOGY: IgM and IgG-ELISAs using Leptospira antigens were established and evaluated in relation to the Microscopic Agglutination Test (MAT). Antigen preparation consisted either saprophytic Leptospira biflexa to detect genus specific antibodies (genus-specific ELISA) or a pool of five most prevalent Leptospira interrogans serovars in Sri Lanka to detect serovar specific antibodies (serovar-specific ELISA). IgM and IgG immune responses in severe and mild leptospirosis patients (n = 100 in each group) were studied. RESULTS: ELISAs showed high repeatability and reproducibility. Serovar-specific IgM-ELISA showed sensitivity of 80.2% and specificity of 89%; genus-specific IgM-ELISA showed sensitivity of 83.3% and specificity of 91%. Serovar and genus-specific IgG-ELISA showed sensitivities of 73.3% and 81.7%, and specificities of 83.33%. Commercial IgM-ELISA showed sensitivity and specificity of 79.2% and 93% respectively. Commercial IgG-ELISA showed sensitivity, specificity of 50% and 96.7% respectively. IgM levels observed in mild and severe leptospirosis (ML & SL) patients were significantly higher than healthy control (HC) group, having absorbance mean of 0.770, 0.778 and 0.163 respectively. In contrast, SL patients had significantly higher mean anti-leptospiral IgG levels compared to both ML and HC groups (0.643, 0.358 and 0.116 respectively; ANOVA, P < 0.001). Presence of anti-leptospiral IgG above OD 0.643 optical density (OD) at 1:100 could predict high risk of severe disease. CONCLUSION: Serovar-specific In-House ELISAs could be used for the laboratory diagnosis of leptospirosis in endemic settings. Observed high levels of anti-leptospiral IgG suggest its value as a predictor for disease severity. KEYWORDS: IgM and IgG antibodies; In-House ELISA; Leptospirosis; Sero-diagnosis. en_US
dc.language.iso en_US en_US
dc.publisher Elsevier en_US
dc.subject ELISA en_US
dc.title Development of an in-house ELISA as an alternative method for the serodiagnosis of leptospirosis en_US
dc.type Article en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record

Search Digital Repository


Browse

My Account